BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5002656)

  • 1. [Blastic transformation of lymphocytes in malignant and immunoreactive diseases].
    Gociu M; Răileanu-Moţoiu I; Popescu IG; Racoveanu C; Berceanu S
    Stud Cercet Med Interna; 1971; 12(3):237-44. PubMed ID: 5002656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Blastic lymphocyte transformation caused by phytohemagglutinin in patients with lymphoproliferative diseases].
    Mantovani G; Petrini MT; Tognella S; Grifoni V
    Boll Soc Ital Biol Sper; 1972 Jul; 48(14):381-5. PubMed ID: 4628299
    [No Abstract]   [Full Text] [Related]  

  • 3. [T-and B-lymphocytes in lymphoproliferative syndromes].
    Girard JP; Fernandes B
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1174-9. PubMed ID: 814616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lysosomal enzymes in lymphocytes. I. Lymphoreticular diseases: comparison of the enzyme content (acid phosphatase, beta-glucuronidase) in unstimulated lymphocytes with blastic transformation after stimulation with phytohemagglutinin beta-Glucuronidase in vitro].
    Brittinger G; König E; Cohnen G; Aberle HG
    Acta Haematol; 1970; 44(4):205-21. PubMed ID: 4994270
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunology of non-Hodgkin lymphomas].
    Ricci C; Cascio G; Bellone G; Borio T; Novarini M; Riposio A; Bozzone D
    Minerva Med; 1983 May; 74(20):1145-56. PubMed ID: 6431332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antibody deficiency syndrome].
    Ricci G
    G Mal Infett Parassit; 1966 Dec; 18(12):Suppl:979-88. PubMed ID: 4173181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blastic transformation of lymphocytes in culture stimulated by phytohemagglutinin (PHA) in hypoplastic anemia and lymphoproliferative diseases].
    Samoĭlina NL; Polianskaia AM
    Probl Gematol Pereliv Krovi; 1969 Oct; 14(10):3-13. PubMed ID: 4983365
    [No Abstract]   [Full Text] [Related]  

  • 8. The spectrum of B cell neoplasia.
    Deegan MJ
    Henry Ford Hosp Med J; 1984; 32(1):20-30. PubMed ID: 6204956
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane-bound IgD on human lymphoid cells, with special reference to immunodeficiency and immunoproliferative diseases.
    Preud'Homme JL; Brouet JC; Seligmann M
    Immunol Rev; 1977; 37():127-51. PubMed ID: 412774
    [No Abstract]   [Full Text] [Related]  

  • 10. [Membrane markers in chronic lymphoproliferative diseases].
    Matutes E; San Miguel JF; Catovsky D
    Med Clin (Barc); 1983 Mar; 80(7):334-50. PubMed ID: 6406774
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological anomalies observed during hyperlymphocytic chronic lymphoid leukemia].
    Homberg JC; Cartron J; Ropars C; Cavaroc M; Salmon C
    Nouv Rev Fr Hematol; 1971; 11(3):476-83. PubMed ID: 4108309
    [No Abstract]   [Full Text] [Related]  

  • 12. Blastic transformation of lymphocytes in some proliferative diseases of the leukocytic system.
    Szewczyk Z; Kopaczynska K
    Arch Immunol Ther Exp (Warsz); 1971; 19(6):781-7. PubMed ID: 5004016
    [No Abstract]   [Full Text] [Related]  

  • 13. T and B cells in clinical disorders.
    Tomasi TB; Stobo JD
    Dis Mon; 1977 Feb; 23(5):1-55. PubMed ID: 401725
    [No Abstract]   [Full Text] [Related]  

  • 14. B-cell neoplasia in man.
    Salmon SE; Seligmann M
    Lancet; 1974 Nov; 2(7891):1230-3. PubMed ID: 4139472
    [No Abstract]   [Full Text] [Related]  

  • 15. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidence of chronic lymphoid leukemia antigen in other malignant hematologic diseases].
    Do TP; Petrányi G; Hollán Z
    Orv Hetil; 1974 Apr; 115(16):930-1. PubMed ID: 4206891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of serum from tuberculous patients on lymphocyte blastic transformation in sarcoidosis].
    Girard JP; Poupon MF; Press P; Favez G
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1986-8. PubMed ID: 5507845
    [No Abstract]   [Full Text] [Related]  

  • 18. Ia antigen expression by human malignant lymphomas: correlation with conventional lymphoid markers.
    Halper JP; Knowles DM; Wang CY
    Blood; 1980 Mar; 55(3):373-82. PubMed ID: 6766752
    [No Abstract]   [Full Text] [Related]  

  • 19. Phytohemagglutinin-induced changes in cultured lymphocytes in the course of some lymphoproliferative and reticuloproliferative diseases. I. Blastic transformation.
    Rozynkowa D; Kowalewski J
    Pol Med J; 1970; 9(4):847-54. PubMed ID: 5273571
    [No Abstract]   [Full Text] [Related]  

  • 20. [The quantification of surface immunoglobulins in lymphoproliferative syndromes].
    Dighiero G; Follezou JY; Roisin JP; Charron D; Bouvet E; Ternyck T; Binet JL
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(1):180-1. PubMed ID: 408791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.